Internal Medicine, Nephrology · Terre Haute, IN
NPI
1730201096
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
476 Buckeye St
Terre Haute, IN, 47804
Phone (812) 238-4708
Groups this clinician bills Medicare through
Medicare paid, 2024
$510K
7,708 services
Medicare patients, 2024
1,371
Average age 76
Drug cost, 2024
$2.6M
9,278 prescriptions
Company payments, 2025
$16K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gaurav K Verma was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,366 times for 694 patients. In total Gaurav K Verma billed 7,708 services in 29 codes, and Medicare paid $510K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,366 | 694 | $12.03 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 1,360 | 484 | $59.55 | $81K |
| 99213 Office E&M - Established | Office | 1,009 | 575 | $56.51 | $57K |
| 99233 Hospital E&M - Subsequent | Facility | 982 | 371 | $89.79 | $88K |
| 99214 Office E&M - Established | Office | 864 | 425 | $60.89 | $53K |
| 90970 ESRD Related Services (not dialysis) | Office | 697 | 16 | $6.88 | $4,793 |
| 99223 Hospital E&M - Initial | Facility | 485 | 395 | $130.07 | $63K |
| 90966 ESRD Related Services (not dialysis) | Office | 138 | 24 | $230.34 | $32K |
| 90961 ESRD Related Services (not dialysis) | Office | 118 | 35 | $230.94 | $27K |
| 90960 ESRD Related Services (not dialysis) | Office | 116 | 31 | $278.10 | $32K |
| 99205 Office E&M - New | Office | 103 | 103 | $157.05 | $16K |
| 90945 Peritoneal Dialysis | Facility | 78 | 26 | $63.30 | $4,937 |
| 99442 Telephone Services | Office | 76 | 47 | $49.64 | $3,773 |
| 90962 ESRD Related Services (not dialysis) | Office | 70 | 22 | $158.52 | $11K |
| 99222 Hospital E&M - Initial | Facility | 57 | 56 | $93.72 | $5,342 |
By year: 2022 $649K for 8,200 services; 2023 $555K for 7,070 services; 2024 $510K for 7,708 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gaurav K Verma prescribed most often to Medicare patients was Furosemide, with 754 prescriptions and refills. In total Gaurav K Verma wrote 9,278 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 754 | 1,351 | 219 | $3,423 |
| Lisinopril Generic | 582 | 1,182 | 168 | $2,375 |
| Farxiga Dapagliflozin Propanediol | 538 | 789 | 119 | $436K |
| Potassium Chloride Generic | 504 | 854 | 135 | $25K |
| Losartan Potassium Generic | 461 | 982 | 141 | $2,874 |
| Torsemide Generic | 441 | 717 | 118 | $15K |
| Allopurinol Generic | 341 | 752 | 90 | $2,766 |
| Hydralazine Hcl Generic | 339 | 660 | 108 | $4,142 |
| Doxazosin Mesylate Generic | 289 | 505 | 72 | $4,769 |
| Kerendia Finerenone | 266 | 361 | 45 | $233K |
| Metoprolol Succinate Generic | 250 | 528 | 73 | $2,395 |
| Tamsulosin Hcl Generic | 204 | 395 | 58 | $1,841 |
| Amlodipine Besylate Generic | 191 | 396 | 55 | $1,012 |
| Atorvastatin Calcium Generic | 185 | 444 | 62 | $809 |
| Valsartan Generic | 183 | 368 | 49 | $2,884 |
Brand drugs: 1,769 claims; generic drugs: 7,509 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gaurav K Verma $16K ($16K in general payments such as food, travel and fees) from 18 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $8,721.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $8,721 |
| Fresenius USA Marketing, Inc. | 12 | $4,609 |
| Travere Therapeutics, Inc. TVTX | 13 | $1,538 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $202 |
| Amgen Inc. AMGN | 14 | $181 |
| Novo Nordisk Inc NVO | 8 | $156 |
| Calliditas Therapeutics US Inc. | 4 | $124 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $99.38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88.41 |
| Ardelyx, Inc. ARDX | 4 | $78.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.